Gyermekkori daganatok: vizsgálatok itt: Kína
611 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Clinical Study on the Benefits of Carbon Nanoparticles Injection Time in Patients With Thyroid Cancer.
- Where
- Xi'an
- Életkor
- 16 év to 80 év
- People
- 400
- Run by
- Second Affiliated Hospital of Xi'an Jiaotong University
See details and how to joinNCT06791005 - No phaseTaking peopleEvaluating the Usefulness of 18F-AlF-FAPI PET/ CT in Orbital Neoplasms
- Where
- Beijing
- Életkor
- 3 év to 80 év
- People
- 50
- Run by
- Peking University Third Hospital
See details and how to joinNCT06791226 - Korai 1. fázisTaking peopleThe Safety and Efficacy of RD06-03 CART Cell Injection in Patients With R/R Acute B-lymphoblastic Leukemia
- Where
- Hefei, Wuhan
- Életkor
- 3 év to 70 év
- People
- 9
- Run by
- Anhui Provincial Hospital
See details and how to joinNCT06307600 - No phaseTaking peopleA Novel CAR-T Combined Expression of IL-15 in the Treatment of Malignant Hematological Tumors
- Where
- Taiyuan
- People
- 45
- Run by
- Shanxi Bethune Hospital
See details and how to joinNCT06783816 - 2. fázisTaking peopleCAR-T-19 Injection in the Treatment of CD19-positive Relapsed/Refractory B-ALL
- Where
- Tianjin
- Életkor
- Up to 25 év
- People
- 100
- Run by
- Beijing Yongtai Ruike Biotechnology Company Ltd
See details and how to joinNCT06179524 - 2. fázisNot yet taking people in KínaAvapritinib Maintenance for AML With KIT Mutations
- Where
- Shanghai
- Életkor
- 14 év to 70 év
- People
- 47
- Run by
- Ruijin Hospital
See details and how to joinNCT06765915 - 2. fázisNot yet taking people in KínaLow-dose Selumetinib for the Treatment of Plexiform Neurofibromas in Chinese Children
- Where
- Chengdu
- Életkor
- 3 év to 18 év
- People
- 50
- Run by
- West China Hospital
See details and how to joinNCT06763315 - 3. fázisCsak meghívásosFHND9041 Versus Afatinib for Non-small Cell Lung Cancer
- Where
- Beijing
- Életkor
- 18 hónap and over
- People
- 350
- Run by
- Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
See details and how to joinNCT06759857 - 1. fázisTaking peopleUGT1A1 Genotype-drien Phase I Study of Irinotecan in VIT Regimen for the Treatment of Pediatric R/R Solid Tumors
- Where
- Guangzhou
- Életkor
- Up to 18 év
- People
- 39
- Run by
- Sun Yat-sen University
See details and how to joinNCT06760117 - No phaseTaking peopleDolasetron for the Prevention of CINV in Children With Acute Lymphoblastic Leukemia
- Where
- Hefei
- Életkor
- 2 év to 17 év
- People
- 500
- Run by
- Anhui Provincial Children's Hospital
See details and how to joinNCT06756022 - 1. fázisTaking peopleCD19/CD22 CAR-T Cell Therapy in MRD-Positive B-lineage Acute Lymphoblastic Leukemia in Children.
- Where
- Guangzhou
- Életkor
- 1 év to 18 év
- People
- 10
- Run by
- Guangzhou Women and Children's Medical Center
See details and how to joinNCT06752785 - No phaseTaking peopleA Technique Improves Urinary Continence in Patients Undergoing Laparoscopic Radical Prostatectomy
- Where
- Suzhou
- Életkor
- Up to 79 év
- People
- 120
- Run by
- Suzhou Municipal Hospital
See details and how to joinNCT06754488 - Korai 1. fázisTaking peopleA Study on the Efficacy of GD2-CAR T Cells in the Treatment of Neuroblastoma
- Where
- Chengdu
- Életkor
- 1 év to 18 év
- People
- 30
- Run by
- The General Hospital of Western Theater Command
See details and how to joinNCT06684639 - No phaseTaking peopleLymph Node Pathologic Grading Strategy
- Where
- Shanghai
- People
- 2998
- Run by
- Fudan University
See details and how to joinNCT06745830 - 2. fázisTaking peopleVHAG in Treating R/R T-ALL/LBL
- Where
- Hangzhou
- Életkor
- 14 év to 74 év
- People
- 50
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06742463 - 2. fázisTaking peopleBlinatumomab Plus Reduced-dose Chemotherapy in Treating B-ALL
- Where
- Hangzhou
- Életkor
- 15 év to 59 év
- People
- 20
- Run by
- First Affiliated Hospital of Zhejiang University
See details and how to joinNCT06742515 - 1/2. fázisTaking peopleCD19 & CD22 Bispecific CAR T Cells in the Treatment of Relapsed/Refractory B Cell Hematologic Tumors
- Where
- Wuhan
- Életkor
- 3 év to 75 év
- People
- 80
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06735495 - 1. fázisTaking peopleRD13-02 Cell Injection in Patients with Relapsed or Refractory CD7-Positive Natural Killer/T Cell Malignancies
- Where
- Wuhan
- Életkor
- 3 év to 70 év
- People
- 10
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06732492 - No phaseTaking peopleThe Value of 68Ga-FAPI PET/CT in Preoperative Evaluation of Thyroid Cancer with Lymph Node Metastases
- Where
- Shanghai
- Életkor
- 16 év to 80 év
- People
- 40
- Run by
- Ruijin Hospital
See details and how to joinNCT06730529 - No phaseTaking peopleZero Ischemia Robot-Assisted MWA Assisted Suture-less Tumor Enucleation of RCC With T1 Stage
- Where
- Shanghai
- Életkor
- 15 év to 80 év
- People
- 80
- Run by
- RenJi Hospital
See details and how to joinNCT06715878 - No phaseTaking peopleAI Recognition of Important Structures in Otolaryngological Surgery
- Where
- Guangzhou
- Életkor
- 6 hónap to 100 év
- People
- 1000
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06726551 - No phaseTaking peopleThe Value of CEUS in Assessing the Response of Cervical Lymph Nodes After NACI for HNSCC
- Where
- Guangzhou
- People
- 100
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06727162 - No phaseTaking peopleFour Cycles Taxane With Trastuzumab and Pertuzumab Neoadjuvant Therapy Among Low Risk HER2 Positive Patients
- Where
- Beijing
- People
- 171
- Run by
- Shu Wang
See details and how to joinNCT06722599 - No phaseTaking peopleChemotherapy Combined With Targeted Therapy for High-risk HER2 Positive and Lymph Node Negative Early Breast Cancer
- Where
- Beijing
- People
- 2916
- Run by
- Shu Wang
See details and how to joinNCT06722612 - 1/2. fázisTaking peopleCD7-specific CAR-T Cell in the Treatment of CD7-positive Relapsed/Refractory Hematologic Tumors
- Where
- Wuhan
- Életkor
- 3 év to 75 év
- People
- 80
- Run by
- Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
See details and how to joinNCT06720324